GILD Archives - Market Exclusive

Home Tags GILD

GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Submission of Matters to...

ME Staff 8-k - May 18, 2017

GILEAD SCIENCES,INC. (NASDAQ:GILD) Files An 8-K Departure of Directors or Certain...

ME Staff 8-k - May 12, 2017

GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Results of Operations and...

ME Staff 8-k - May 2, 2017

Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH) An Ace Up Gilead Sciences (NASDAQ:GILD)’s...

David Rich - December 28, 2016

Matinas BioPharma Holdings Inc. (OTCMKTS:MTNB) Can Take A $350M Antifungal Market...

David Rich - November 23, 2016

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

David Rich - April 11, 2016

Movers and Shakers in Biotech: The Week so Far

Jennifer Aldershot - February 16, 2016

EDITOR PICKS

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

June 21, 2017

Here’s What Just Happened With Clovis Oncology, Inc. (NASDAQ:CLVS) and Rigel...

June 20, 2017

Biotech Movers: Celsion Corporation (NASDAQ:CLSN) and Neos Therapeutics Inc (NASDAQ:NEOS)

June 19, 2017

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

June 6, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: GILD

GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Submission of Matters to...

GILEAD SCIENCES,INC. (NASDAQ:GILD) Files An 8-K Departure of Directors or Certain...

GILEAD SCIENCES, INC. (NASDAQ:GILD) Files An 8-K Results of Operations and...

Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH) An Ace Up Gilead Sciences (NASDAQ:GILD)’s...

Matinas BioPharma Holdings Inc. (OTCMKTS:MTNB) Can Take A $350M Antifungal Market...

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Movers and Shakers in Biotech: The Week so Far

EDITOR PICKS

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

Here’s What Just Happened With Clovis Oncology, Inc. (NASDAQ:CLVS) and Rigel...

Biotech Movers: Celsion Corporation (NASDAQ:CLSN) and Neos Therapeutics Inc (NASDAQ:NEOS)

POPULAR POSTS

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY